Working together
We start with one therapy and build from there.
We work with market access, HEOR and launch teams on rare and specialty therapies, before launch and after.
What your team receives
Findings your team can act on.
- A payer-by-payer view of likely decisions for your therapy, and why
- Findings tied to the exact policy language and the evidence behind them
- Where each policy stands against the evidence, and what can be done about it
- Alerts on meaningful changes, routed to the people who own them
Trust and security
Built by people who have worked inside the system.
Your data stays yours
Anything you share shapes your plan only. It is never shown to another customer.
Enterprise-grade by default
We run on enterprise infrastructure with no retention of your data by the models we use.
Deployed inside payers
Our team has deployed AI products inside a national pharmacy benefit company and a health plan.
Held to an expert standard
Payer and clinical reviewers set the standard. Their judgments train and test the AI, so it reads policy at scale and assesses it the way they would.
Tell us the therapy, the indication and where you are in the launch.
We will propose a starting scope.